PHV-wordings
Methotrexate New
PSUFU
|
03/02/2023
Further information is available on the HMA-Website.
Methoxyflurane New
PSUR-outcome
|
02/02/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Bleomycin New
PSUR-outcome
|
02/02/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Fentanyl (transdermal patches, solution for injection) New
PSUR-outcome
|
31/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Omeprazole New
PSUR-outcome
|
30/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Vinorelbine New
PSUR-outcome
|
30/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Triptorelin New
PSUR-outcome
|
30/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amfepramone
Referral
|
19/01/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Amoxicillin / Clavulanate
PSUR-outcome
|
17/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Combined medicinal products containing amoxicillin
Additional template
|
17/01/2023
Further information is available in the CMDh press release (Report from the meeting held on 8-10 November 2022) on the HMA-Website.
